Skip to main content
NCBI home page
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2004 Jan 7;56:243–273. doi: 10.1016/S0065-3527(01)56030-3

DNA immunization and central nervous system viral infection

J Lindsay Whitton ∗, Robert S Fujinami †
PMCID: PMC7130639  PMID: 11450302

Abstract

This chapter discusses the virus infections of the central nervous system (CNS) and DNA vaccines. Mild central nervous system (CNS) symptoms, such as headache and drowsiness, can result from systemically elevated cytokine levels and therefore are common in many virus infections, even in the absence of the infection of the CNS. CNS infection is quite unusual and is initiated either as a result of the viremia or, more rarely, as a result of neural spread. The poliovirus infects the anterior horn motor neurons of the spinal cord, causing poliomyelitis, the disease for which the virus is named. DNA vaccination is a relatively new entrant in the vaccine sweepstakes, but is viewed with optimism, for a number of reasons. DNA vaccines encoding the nucleoprotein from lymphocytic choriomeningitis virus can confer protection against the normally lethal intracranial challenge. In rabies, in a mouse model, immunization with plasmids encoding the rabies glycoprotein conferred complete protection against subsequent viral challenge. Several virus-induced CNS diseases may be explained by their triggering of autoimmunity. Experimental autoimmune encephalomyelitis is a well-characterized CNS disease induced by the administration of certain CNS proteins.

References

  1. Allan J.E, Doherty P.C. Immune T cells can protect or induce fatal neurological disease in murine lymphocytic choriomeningitis. Cell Immunol. 1985;90:401–407. doi: 10.1016/0008-8749(85)90204-7. [DOI] [PubMed] [Google Scholar]
  2. Altintas A, Cai Z, Pease L.R, Rodriguez M. Differential expression of H-2K and H-2D in the central nervous system of mice infected with Theiler's virus. J. Immunol. 1993;151:2803–2812. [PubMed] [Google Scholar]
  3. An L.L, Whitton J.L. A multivalent minigene vaccine, containing B cell, CTL, and Th epitopes from several microbes, induces appropriate responses in vivo, and confers protection against more than one pathogen. J. Virol. 1997;71:2292–2302. doi: 10.1128/jvi.71.3.2292-2302.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. An L.L, Whitton J.L. Multivalent Minigene Vaccines Against Infectious Disease. Curr. Opin. Molec. Ther. 1999;1:16–21. [PubMed] [Google Scholar]
  5. Andersson J, Isberg B, Christensson B, Veress B, Linde A, Bratel T. Interferon-γ deficiency in generalized Epstein-Barr virus infection with interstitial lymphoid and granulomatous pneumonia, focal cerebral lesions, and genital ulcers: remission following IFN-gamma substitution therapy. Clin. Infect. Dis. 1999;28:1036–1042. doi: 10.1086/514733. [DOI] [PubMed] [Google Scholar]
  6. Arevalo J.H, Taussig M.J, Wilson I.A. Molecular basis of crossreactivity and the limits of antibody-antigen complementarity. Nature. 1993;365:859–863. doi: 10.1038/365859a0. [DOI] [PubMed] [Google Scholar]
  7. Ashok M.S, Rangarajan P.N. Immunization with plasmid DNA encoding the envelope glycoprotein of Japanese encephalitis virus confers significant protection against intracerebral viral challenge without inducing detectable antiviral antibodies. Vaccine. 1999;18:68–75. doi: 10.1016/s0264-410x(99)00180-2. [DOI] [PubMed] [Google Scholar]
  8. Barbas C.F, Kang A.S, Lerner R.A, Benkovic S.J. Vol. 88. 1991. Assembly of combinatorial antibody libraries on phage surfaces: the gene III site; pp. 7978–7982. (Proc. Natl. Acad. Sci. U.S.A.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Barnett L.A, Whitton J.L, Wada Y, Fujinami R.S. Enhancement of autoimmune disease using recombinant vaccinia virus encoding myelin proteolipid protein. J. Neuroimmunol. 1993;44:15–25. doi: 10.1016/0165-5728(93)90263-x. [DOI] [PubMed] [Google Scholar]
  10. Barnett L.A, Whitton J.L, Wang L.Y, Fujinami R.S. Virus encoding an encephalitogenic peptide protects mice from experimental allergic encephalomyelitis. J. Neuroimmunol. 1996;64:163–173. doi: 10.1016/0165-5728(95)00165-4. [DOI] [PubMed] [Google Scholar]
  11. Bergelson L.D. Gangliosides and antitumor immunity. Clin. Investig. 1993;71:590–594. doi: 10.1007/BF00184480. [DOI] [PubMed] [Google Scholar]
  12. Bergelson L.D. Serum gangliosides as endogenous immunomodulators. Immunol. Today. 1995;16:483–486. doi: 10.1016/0167-5699(95)80032-8. [DOI] [PubMed] [Google Scholar]
  13. Bergelson L.D, Dyatlovitskaya E.V, Klyuchareva T.E, Kryukova E.V, Lemenovskaya A.F, Matveeva V.A, Sinitsyna E.V. The role of glycosphingolipids in natural immunity. Gangliosides modulate the cytotoxicity of natural killer cells. Eur. J. Immunol. 1989;19:1979–1983. doi: 10.1002/eji.1830191102. [DOI] [PubMed] [Google Scholar]
  14. Bessen R.A, Kocisko D.A, Raymond G.J, Nandan S, Lansbury P.T, Caughey B. Non-genetic propagation of strain-specific properties of scrapie prion protein. Nature. 1995;375:698–700. doi: 10.1038/375698a0. [DOI] [PubMed] [Google Scholar]
  15. Betmouni S, Perry V.H, Gordon J.L. Evidence for an early inflammatory response in the central nervous system of mice with scrapie. Neuroscience. 1996;74:1–5. doi: 10.1016/0306-4522(96)00212-6. [DOI] [PubMed] [Google Scholar]
  16. Bjorkman P.J, Saper M.A, Samraoui B, Bennett W.S, Strominger J.L, Wiley D.C. Structure of the human class I histocompatibility antigen HLA-A2. Nature. 1987;329:506–512. doi: 10.1038/329506a0. [DOI] [PubMed] [Google Scholar]
  17. Bjorkman P.J, Saper M.A, Samraoui B, Bennett W.S, Strominger J.L, Wiley D.C. The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature. 1987;329:512–518. doi: 10.1038/329512a0. [DOI] [PubMed] [Google Scholar]
  18. Blackbourn D.J, Mackewicz C.E, Barker E, Levy J.A. Human CD8+ cell non-cytolytic anti-HIV activity mediated by a novel cytokine. Res. Immunol. 1994;145:653–658. doi: 10.1016/s0923-2494(05)80049-5. [DOI] [PubMed] [Google Scholar]
  19. Bode L, Zimmermann W, Ferszt R, Steinbach F, Ludwig H. Borna disease virus genome transcribed and expressed in psychiatric patients. Nat. Med. 1995;1:232–236. doi: 10.1038/nm0395-232. [DOI] [PubMed] [Google Scholar]
  20. Briese T, Schneemann A, Lewis A.J, Park Y.S, Kim S, Ludwig H, Lipkin W.I. Vol. 91. 1994. Genomic organization of Borna disease virus; pp. 4362–4366. (Proc. Natl. Acad. Sci. U.S.A.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Bueler H, Aguzzi A, Sailer A, Greiner R.A, Autenried P, Aguet M, Weissmann C. Mice devoid of PrP are resistant to scrapie. Cell. 1993;73:1339–1347. doi: 10.1016/0092-8674(93)90360-3. [DOI] [PubMed] [Google Scholar]
  22. Bueler H, Fischer M, Lang Y, Bluethmann H, Lipp H.P, DeArmond S.J, Prusiner S.B, Aguet M, Weissmann C. Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature. 1992;356:577–582. doi: 10.1038/356577a0. [DOI] [PubMed] [Google Scholar]
  23. Cardoso A.I, Blixenkrone-Moller M, Fayolle J, Liu M.A, Buckland R, Wild T.F. Immunization with plasmid DNA encoding for the measles virus hemagglutinin and nucleoprotein leads to humoral and cell-mediated immunity. Virol. 1996;225:293–299. doi: 10.1006/viro.1996.0603. [DOI] [PubMed] [Google Scholar]
  24. Ceccaldi P.E, Gillet J.P, Tsiang H. Inhibition of the transport of rabies virus in the central nervous system. J. Neuropathol. Exp. Neurol. 1989;48:620–630. doi: 10.1097/00005072-198911000-00004. [DOI] [PubMed] [Google Scholar]
  25. Childs J.E, Glass G.E, Korch G.W, Ksiazek T.G, Leduc J.W. Lymphocytic choriomeningitis virus infection and house mouse (Mus musculus) distribution in urban Baltimore. Am. J. Trop. Med. Hyg. 1992;47:27–34. doi: 10.4269/ajtmh.1992.47.27. [DOI] [PubMed] [Google Scholar]
  26. Childs J.E, Glass G.E, Ksiazek T.G, Rossi C.A, Oro J.G, Leduc J.W. Human-rodent contact and infection with lymphocytic choriomeningitis and Seoul viruses in an inner-city population. Am. J. Trop. Med. Hyg. 1991;44:117–121. doi: 10.4269/ajtmh.1991.44.117. [DOI] [PubMed] [Google Scholar]
  27. Colombage G, Hall R, Pavy M, Lobigs M. DNA-based and alphavirus-vectored immunisation with prM and E proteins elicits long-lived and protective immunity against the flavivirus, Murray Valley encephalitis virus. Virol. 1998;250:151–163. doi: 10.1006/viro.1998.9357. [DOI] [PubMed] [Google Scholar]
  28. Crowe J.E, Murphy B.R, Chanock R.M, Williamson R.A, Barbas C.F, III, Burton D.R. Vol. 91. 1994. Recombinant human RSV monoclonal antibody Fab is effective therapeutically when introduced directly into the lungs of respiratory syncytial virus-infected mice; pp. 1386–1390. (Proc. Natl. Acad. Sci. U.S.A.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. de la Torre J.C. Molecular biology of borna disease virus: prototype of a new group of animal viruses. J. Virol. 1994;68:7669–7675. doi: 10.1128/jvi.68.12.7669-7675.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. de la Torre J.C, Bode L, Durrwald R, Cubitt B, Ludwig H. Sequence characterization of human Borna disease virus. Virus Res. 1996;44:33–44. doi: 10.1016/0168-1702(96)01338-x. [DOI] [PubMed] [Google Scholar]
  31. de la Torre J.C, Gonzalez-Dunia D, Cubitt B, Mallory M, Mueller-Lantzsch N, Grasser F.A, Hansen L.A, Masliah E. Detection of borna disease virus antigen and RNA in human autopsy brain samples from neuropsychiatric patients. Virol. 1996;223:272–282. doi: 10.1006/viro.1996.0479. [DOI] [PubMed] [Google Scholar]
  32. Dixon J.E, Allan J.E, Doherty P.C. The acute inflammatory process in murine lymphocytic choriomeningitis is dependent on Lyt-2+ immune T cells. Cell Immunol. 1987;107:8–14. doi: 10.1016/0008-8749(87)90260-7. [DOI] [PubMed] [Google Scholar]
  33. Donnelly J.J, Ulmer J.B, Liu M.A. DNA vaccines. Life Sci. 1997;60:163–172. doi: 10.1016/s0024-3205(96)00502-4. [DOI] [PubMed] [Google Scholar]
  34. Dorries K. Molecular biology and pathogenesis of human polyomavirus infections. Dev. Biol. Stand. 1998;94:71–79. [PubMed] [Google Scholar]
  35. Fox L, Alford M, Achim C, Mallory M, Masliah E. Neurodegeneration of somatostatin-immunoreactive neurons in HIV encephalitis. J. Neuropathol. Exp. Neurol. 1997;56:360–368. doi: 10.1097/00005072-199704000-00004. [DOI] [PubMed] [Google Scholar]
  36. Fujinami R.S, Oldstone M.B.A. Antiviral antibody reacting on the plasma membrane alters measles virus expression inside the cell. Nature. 1979;279:529–530. doi: 10.1038/279529a0. [DOI] [PubMed] [Google Scholar]
  37. Gendelman H.E, Wolinsky J.S, Johnson R.T, Pressman N.J, Pezeshkpour G.H, Boisset G.F. Measles encephalomyelitis: lack of evidence of viral invasion of the central nervous system and quantitative study of the nature of demyelination. Ann. Neurol. 1984;15:353–360. doi: 10.1002/ana.410150409. [DOI] [PubMed] [Google Scholar]
  38. Gordon J, Khalili K. The human polyomavirus, JCV, and neurological diseases (review) Int. J. Mol. Med. 1998;1:647–655. doi: 10.3892/ijmm.1.4.647. [DOI] [PubMed] [Google Scholar]
  39. Guidotti L.G, Chisari F.V. To kill or to cure: options in host defense against viral infection. Current Opinion in Immunology. 1996;8:478–483. doi: 10.1016/s0952-7915(96)80034-3. [DOI] [PubMed] [Google Scholar]
  40. Guidotti L.G, Ishikawa T, Hobbs M.V, Matzke B, Schreiber R, Chisari F.V. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity. 1996;4:25–36. doi: 10.1016/s1074-7613(00)80295-2. [DOI] [PubMed] [Google Scholar]
  41. Guidotti L.G, Rochford R, Chung J, Shapiro M, Purcell R, Chisari F.V. Viral Clearance Without Destruction of Infected Cells During Acute HBV Infection. Science. 1999;284:825–829. doi: 10.1126/science.284.5415.825. [DOI] [PubMed] [Google Scholar]
  42. Hassett D.E, Whitton J.L. DNA Immunization. Trends in Microbiol. 1996;4:307–312. doi: 10.1016/0966-842x(96)10048-2. [DOI] [PubMed] [Google Scholar]
  43. Hassett D.E, Zhang J, Slifka M.K, Whitton J.L. Immune responses following neonatal DNA immunization are long-lived, abundant, and qualitatively similar to those induced by conventional vaccination. J. Virol. 2000;74:2620–2627. doi: 10.1128/jvi.74.6.2620-2627.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Hassett D.E, Zhang J, Whitton J.L. Neonatal DNA immunization with an internal viral protein is effective in the presence of maternal antibodies and protects against subsequent viral challenge. J. Virol. 1997;71:7881–7888. doi: 10.1128/jvi.71.10.7881-7888.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Hsu S.C, Obeid O.E, Collins M, Iqbal M, Chargelegue D, Steward M.W. Protective cytotoxic T lymphocyte responses against paramyxoviruses induced by epitope-based DNA vaccines: involvement of IFN-γ. Int. Immunol. 1998;10:1441–1447. doi: 10.1093/intimm/10.10.1441. [DOI] [PubMed] [Google Scholar]
  46. Huang S, Hendriks W, Althage A, Hemmi S, Bluethmann H, Kamijo R, Vilcek J, Zinkernagel R.M, Aguet M. Immune response in mice that lack the interferon-y receptor. Science. 1993;259:1742–1745. doi: 10.1126/science.8456301. [DOI] [PubMed] [Google Scholar]
  47. Irani D.N. The susceptibility of mice to immune-mediated neurologic disease correlates with the degree to which their lymphocytes resist the effects of brain-derived gangliosides. J. Immunol. 1998;161:2746–2752. [PubMed] [Google Scholar]
  48. Irani D.N, Lin K.I, Griffin D.E. Brain-derived gangliosides regulate the cytokine production and proliferation of activated T cells. J. Immunol. 1996;157:4333–4340. [PubMed] [Google Scholar]
  49. Jensen P.N, Major E.O. Viral variant nucleotide sequences help expose leukocytic positioning in the JC virus pathway to the CNS. J. Leukoc. Biol. 1999;65:428–438. doi: 10.1002/jlb.65.4.428. [DOI] [PubMed] [Google Scholar]
  50. Joly E, Mucke L, Oldstone M.B.A. Viral persistence in neurons explained by lack of major histocompatibility class I expression. Science. 1991;253:1283–1285. doi: 10.1126/science.1891717. [DOI] [PubMed] [Google Scholar]
  51. Joly E, Oldstone M.B.A. Neuronal cells are deficient in loading peptides onto MHC class I molecules. Neuron. 1992;8:1185–1190. doi: 10.1016/0896-6273(92)90138-4. [DOI] [PubMed] [Google Scholar]
  52. Kagi D, Ledermann B, Burki K, Seiler P, Odermatt B, Olsen K.J, Podack E.R, Zinkernagel R.M, Hengartner H. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature. 1994;369:31–37. doi: 10.1038/369031a0. [DOI] [PubMed] [Google Scholar]
  53. Kagi D, Vignaux F, Ledermann B, Burki K, Depraetere V, Nagata S, Hengartner H, Golstein P. Fas and Perforin Pathways as Major Mechanisms of T Cell-Mediated Cytotoxicity. Science. 1994;265:528–530. doi: 10.1126/science.7518614. [DOI] [PubMed] [Google Scholar]
  54. Kang A.S, Barbas C.F, Janda K.D, Benkovic S.J, Lerner R.A. Vol. 88. 1991. Linkage of recognition and replication functions by assembling combinatorial antibody Fab libraries along phage surfaces; pp. 4363–4366. (Proc. Natl. Acad. Sci. U.S.A.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Karpus W.J, Pope J.G, Peterson J.D, Dal Canto M.C, Miller S.D. Inhibition of Theiler's virus-mediated demyelination by peripheral immune tolerance induction. J. Immunol. 1995;155:947–957. [PubMed] [Google Scholar]
  56. Klavinskis L.S, Whitton J.L, Oldstone M.B.A. Molecularly engineered vaccine which expresses an immunodominant T-cell epitope induces cytotoxic T lymphocytes that confer protection from lethal virus infection. J. Virol. 1989;63:4311–4316. doi: 10.1128/jvi.63.10.4311-4316.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Kocisko D.A, Come J.H, Priola S.A, Chesebro B, Raymond G.J, Lansbury P.T, Caughey B. Cell-free formation of protease-resistant prion protein. Nature. 1994;370:471–474. doi: 10.1038/370471a0. [DOI] [PubMed] [Google Scholar]
  58. Kocisko D.A, Priola S.A, Raymond G.J, Chesebro B, Lansbury P.T.J, Caughey B. Vol. 92. 1995. Species specificity in the cell-free conversion of prion protein to protease-resistant forms: a model for the scrapie species barrier; pp. 3923–3927. (Proc. Natl. Acad. Sci. U.S.A.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Konishi E, Yamaoka M, Khin S.W, Kurane I, Mason P.W. Induction of protective immunity against Japanese encephalitis in mice by immunization with a plasmid encoding Japanese encephalitis virus premembrane and envelope genes. J. Virol. 1998;72:4925–4930. doi: 10.1128/jvi.72.6.4925-4930.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Konishi E, Yamaoka M, Khin S.W, Kurane I, Takada K, Mason P.W. The anamnestic neutralizing antibody response is critical for protection of mice from challenge following vaccination with a plasmid encoding the Japanese encephalitis virus premembrane and envelope genes. J. Virol. 1999;73:5527–5534. doi: 10.1128/jvi.73.7.5527-5534.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Krasemann S, Groschup M, Hunsmann G, Bodemer W. Induction of antibodies against human prion proteins (PrP) by DNA- mediated immunization of PrP0/0 mice. J. Immunol. Methods. 1996;199:109–118. doi: 10.1016/s0022-1759(96)00165-2. [DOI] [PubMed] [Google Scholar]
  62. Kuwahara C, Takeuchi A.M, Nishimura T, Haraguchi K, Kubosaki A, Matsumoto Y, Saeki K, Matsumoto Y, Yokoyama T, Itohara S, Onodera T. Prions prevent neuronal cell-line death. Nature. 1999;400:225–226. doi: 10.1038/22241. [DOI] [PubMed] [Google Scholar]
  63. Lampson L.A, Fisher C.A. Vol. 81. 1984. Weak HLA and beta 2-microglobulin expression of neuronal cell lines can be modulated by interferon; pp. 6476–6480. (Proc. Natl. Acad. Sci. U.S.A.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Lampson L.A, Fisher C.A, Whelan J.P. Striking paucity of HLA-A, B, C and beta 2-microglobulin on human neuroblastoma cell lines. J. Immunol. 1983;130:2471–2478. [PubMed] [Google Scholar]
  65. Lampson L.A, Hickey W.F. Monoclonal antibody analysis of MHC expression in human brain biopsies: tissue ranging from “histologically normal” to that showing different levels of glial tumor involvement. J. Immunol. 1986;136:4054–4062. [PubMed] [Google Scholar]
  66. Lang W, Wiley C, Lampert P. Theiler's virus encephalomyelitis is unaffected by treatment with myelin components. J. Neuroimmunol. 1985;9:109–113. doi: 10.1016/s0165-5728(85)80011-4. [DOI] [PubMed] [Google Scholar]
  67. Larsen P.D, Chartrand S.A, Tomashek K.M, Hauser L.G, Ksiazek T.G. Hydrocephalus complicating lymphocytic choriomeningitis virus infection. Pediatr. Infect. Dis. J. 1993;12:528–531. doi: 10.1097/00006454-199306000-00013. [DOI] [PubMed] [Google Scholar]
  68. Lawrence D.M, Vaughn M.M, Belman A.R, Cole J.S, Rall G.F. Immune response-mediated protection of adult but not neonatal mice from neuron-restricted measles virus infection and central nervous system disease. J. Virol. 1999;73:1795–1801. doi: 10.1128/jvi.73.3.1795-1801.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Levine B, Hardwick J.M, Trapp B.D, Crawford T.O, Bollinger R.C, Griffin D.E. Antibody-mediated clearance of alphavirus infection from neurons. Science. 1991;254:856–860. doi: 10.1126/science.1658936. [DOI] [PubMed] [Google Scholar]
  70. Levy J.A, Mackewicz C.E, Barker E. Controlling HIV pathogenesis: the role of the noncytotoxic anti-HIV response of CD8+ T cells. Immunol. Today. 1996;17:217–224. doi: 10.1016/0167-5699(96)10011-6. [DOI] [PubMed] [Google Scholar]
  71. Lin Y.L, Chen L.K, Liao C.L, Yeh C.T, Ma S.H, Chen J.L, Huang Y.L, Chen S.S, Chiang H.Y. DNA immunization with Japanese encephalitis virus nonstructural protein NS1 elicits protective immunity in mice. J. Virol. 1998;72:191–200. doi: 10.1128/jvi.72.1.191-200.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Lindsley M.D, Patick A.K, Prayoonwiwat N, Rodriguez M. Vol. 67. 1992. Coexpression of class I major histocompatibility antigen and viral RNA in central nervous system of mice infected with Theiler's virus: a model for multiple sclerosis; pp. 829–838. (Mayo Clin. Proc.). [DOI] [PubMed] [Google Scholar]
  73. Liu M.A, McClements W, Ulmer J.B, Shiver J, Donnelly J. Immunization of non-human primates with DNA vaccines. Vaccine. 1997;15:909–912. doi: 10.1016/s0264-410x(96)00280-0. [DOI] [PubMed] [Google Scholar]
  74. Lodmell D.L, Ray N.B, Parnell M.J, Ewalt L.C, Hanlon C.A, Shaddock J.H, Sanderlin D.S, Rupprecht C.E. DNA immunization protects nonhuman primates against rabies virus. Nat. Med. 1998;4:949–952. doi: 10.1038/nm0898-949. [DOI] [PubMed] [Google Scholar]
  75. Martinez X, Brandt C, Saddallah F, Tougne C, Barrios C, Wild F, Dougan G, Lambert P.H, Siegrist C.A. Vol. 94. 1997. DNA immunization circumvents deficient induction of T helper type 1 and cytotoxic T lymphocyte responses in neonates and during early life; pp. 8726–8731. (Proc. Natl. Acad. Sci. U.S.A.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Moller A.A, Gasser T, Jager H, Hedl A. Clinical course of subacute HIV encephalitis. J. Neuroimmunol. 1988;20:145–147. doi: 10.1016/0165-5728(88)90146-4. [DOI] [PubMed] [Google Scholar]
  77. Neumann H, Cavalie A, Jenne D.E, Wekerle H. Induction of MHC class I genes in neurons. Science. 1995;269:549–552. doi: 10.1126/science.7624779. [DOI] [PubMed] [Google Scholar]
  78. Neumann H, Schmidt H, Cavalie A, Jenne D, Wekerle H. Major histocompatibility complex (MHC) class I gene expression in single neurons of the central nervous system: differential regulation by interferon (IFN)-gamma and tumor necrosis factor (TNF)-alpha. J. Exp. Med. 1997;185:305–316. doi: 10.1084/jem.185.2.305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Nowak M.A, Bonhoeffer S, Hill A.M, Boehme R, Thomas H.C, McDade H. Vol. 93. 1996. Viral dynamics in hepatitis B virus infection; pp. 4398–4402. (Proc. Natl. Acad. Sci. U.S.A.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Oehen S, Hengartner H, Zinkernagel R.M. Vaccination for disease. Science. 1991;251:195–198. doi: 10.1126/science.1824801. [DOI] [PubMed] [Google Scholar]
  81. Ogra P.L, Garofalo R. Secretory antibody response to viral vaccines. Prog. Med. Virol. 1990;37:156–189. [PubMed] [Google Scholar]
  82. Oldstone M.B.A. Molecular mimicry and immune-mediated diseases. FASEB J. 1998;12:1255–1265. doi: 10.1096/fasebj.12.13.1255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Oldstone M.B.A, Blount P, Southern P.J, Lampert P.W. Cytoimmunotherapy for persistent virus infection reveals a unique clearance pattern from the central nervous system. Nature. 1986;321:239–243. doi: 10.1038/321239a0. [DOI] [PubMed] [Google Scholar]
  84. Outram G.W, Dickinson A.G, Fraser H. Reduced susceptibility to scrapie in mice after steroid administration. Nature. 1974;249:855–856. doi: 10.1038/249855a0. [DOI] [PubMed] [Google Scholar]
  85. Pedroza Martins L, Lau L.L, Asano M.S, Ahmed R. DNA vaccination against persistent viral infection. J. Virol. 1995;69:2574–2582. doi: 10.1128/jvi.69.4.2574-2582.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  86. Phillpotts R.J, Venugopal K, Brooks T. Immunisation with DNA polynucleotides protects mice against lethal challenge with St. Louis encephalitis virus. Arch. Virol. 1996;141:743–749. doi: 10.1007/BF01718332. [DOI] [PubMed] [Google Scholar]
  87. Planz O, Bilzer T, Stitz L. Immunopathogenic role of T-cell subsets in Borna disease virus-induced progressive encephalitis. J. Virol. 1995;69:896–903. doi: 10.1128/jvi.69.2.896-903.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. Podack E.R, Lowrey D.M, Lichtenheld M, Hameed A. Function of granule perforin and esterases in T cell-mediated reactions. Components required for delivery of molecules to target cells. Ann. N. Y. Acad. Sci. 1988;532:292–302. doi: 10.1111/j.1749-6632.1988.tb36347.x. [DOI] [PubMed] [Google Scholar]
  89. Prusiner S.B, Groth D, Serban A, Koehler R, Foster D, Torchia M, Burton D, Yang S.L, DeArmond S.J. Vol. 90. 1993. Ablation of the prion protein (PrP) gene in mice prevents scrapie and facilitates production of anti-PrP antibodies; pp. 10608–10612. (Proc. Natl. Acad. Sci. U.S.A.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. Rall G.F, Manchester M, Daniels L.R, Callahan E.M, Belman A.R, Oldstone M.B. Vol. 94. 1997. A transgenic mouse model for measles virus infection of the brain; pp. 4659–4663. (Proc. Natl. Acad. Sci. U.S.A.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  91. Ramsay A.J, Ruby J, Ramshaw I.A. A case for cytokines as effector molecules in the resolution of virus infection. Immunol. Today. 1993;14:155–157. doi: 10.1016/0167-5699(93)90277-R. [DOI] [PubMed] [Google Scholar]
  92. Ray N.B, Ewalt L.C, Lodmell D.L. Nanogram quantities of plasmid DNA encoding the rabies virus glycoprotein protect mice against lethal rabies virus infection. Vaccine. 1997;15:892–895. doi: 10.1016/s0264-410x(96)00281-2. [DOI] [PubMed] [Google Scholar]
  93. Rickinson A.B, Murray R.J, Brooks J, Griffin H, Moss D.J, Masucci M.G. T cell recognition of Epstein-Barr virus associated lymphomas. Cancer Surv. 1992;13:53–80. [PubMed] [Google Scholar]
  94. Rini J.M, Schulte-Gahmen U, Wilson I.A. Structural evidence for induced fit as a mechanism for antibody- antigen recognition. Science. 1992;255:959–965. doi: 10.1126/science.1546293. [DOI] [PubMed] [Google Scholar]
  95. Rodriguez F, An L.L, Harkins S, Zhang J, Yokoyama M, Widera G, Fuller J.T, Kincaid C, Campbell I.L, Whitton J.L. DNA immunization with minigenes: low frequency of memory CTL and inefficient antiviral protection are rectified by ubiquitination. J. Virol. 1998;72:5174–5181. doi: 10.1128/jvi.72.6.5174-5181.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  96. Rodriguez F, Zhang J, Whitton J.L. DNA immunization: ubiquitination of a viral protein enhances CTL induction, and antiviral protection, but abrogates antibody induction. J. Virol. 1997;71:8497–8503. doi: 10.1128/jvi.71.11.8497-8503.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  97. Ruby J, Ramshaw I.A. The antiviral activity of immune CD8+ T cells is dependent on interferon-gamma. Lymphokine Cytokine. Res. 1991;10:353–358. [PubMed] [Google Scholar]
  98. Schenk D, Barbour R, Dunn W, Gordon G, Grajeda H, Guido T, Hu K, Huang J, Johnson-Wood K, Khan K, Kholodenko D, Lee M, Liao Z, Lieberburg I, Motter R, Mutter L, Soriano F, Shopp G, Vasquez N, Vandevert C, Walker S, Wogulis M, Yednock T, Games D, Seubert P. Immunization with amyloid-beta attenuates Alzheimer-diseae-like pathology in the PDAPP mouse. Nature. 1999;400:173–177. doi: 10.1038/22124. [DOI] [PubMed] [Google Scholar]
  99. Schiff J.A, Schaefer J.A, Robinson J.E. Epstein-Barr virus in cerebrospinal fluid during infectious mononucleosis encephalitis. Yale J. Biol. Med. 1982;55:59–63. [PMC free article] [PubMed] [Google Scholar]
  100. Schirmbeck R, Bohm W, Ando K, Chisari F.V, Reimann J. Nucleic acid vaccination primes hepatitis B virus surface antigen-specific cytotoxic T lymphocytes in nonresponder mice. J. Virol. 1995;69:5929–5934. doi: 10.1128/jvi.69.10.5929-5934.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  101. Schuh T, Schultz J, Moelling K, Pavlovic J. DNA-based vaccine against La Crosse virus: protective immune response mediated by neutralizing antibodies and CD4+ T cells. Hum. Gene Ther. 1999;10:1649–1658. doi: 10.1089/10430349950017653. [DOI] [PubMed] [Google Scholar]
  102. Shresta S, Pham C.T, Thomas D.A, Graubert T.A, Ley T.J. How do cytotoxic lymphocytes kill their targets? Curr Opin. Immunol. 1998;10:581–587. doi: 10.1016/s0952-7915(98)80227-6. [DOI] [PubMed] [Google Scholar]
  103. Sigurdsson B. Rida, a chronic encephalitis of sheep with general remarks on infections which develop slowly and some of their special characteristics. Br. Vet. J. 1954;110:341–354. [Google Scholar]
  104. Sigurdsson B. Observations on three slow infections of sheep. Br. Vet. J. 1954;110:255–270. [Google Scholar]
  105. Slifka M.K, Rodriguez F, Whitton J.L. Rapid on/off cycling of cytokine production by virus-specific CD8+ T cells. Nature. 1999;401:76–79. doi: 10.1038/43454. [DOI] [PubMed] [Google Scholar]
  106. Slifka M.K, Whitton J.L. Activated and memory CD8+ T cells can be distinguished by thier cytokine profiles and phenotypic markers. J. Immunol. 2000 doi: 10.4049/jimmunol.164.1.208. (in press) [DOI] [PubMed] [Google Scholar]
  107. Spiegelberg H.L. The role of interleukin-4 in IgE and IgG subclass formation. Springer Semin. Immunopathol. 1990;12:365–383. doi: 10.1007/BF00225324. [DOI] [PubMed] [Google Scholar]
  108. Stitz L, Planz O, Bilzer T, Frei K, Fontana A. Transforming growth factor-beta modulates T cell-mediated encephalitis caused by Borna disease virus. Pathogenic importance of CD8+ cells and suppression of antibody formation. J. Immunol. 1991;147:3581–3586. [PubMed] [Google Scholar]
  109. Suda T, Nagata S. Purification and characterization of the Fas-ligand that induces apoptosis. J. Exp. Med. 1994;179:873–879. doi: 10.1084/jem.179.3.873. [DOI] [PMC free article] [PubMed] [Google Scholar]
  110. Tishon A, Lewicki H, Rall G.F, von Herrath M.G, Oldstone M.B.A. An essential role for type 1 interferon-gamma in terminating persistent viral infection. Virol. 1995;212:244–250. doi: 10.1006/viro.1995.1477. [DOI] [PubMed] [Google Scholar]
  111. Tolley N.D, Tsunoda I, Fujinami R.S. DNA vaccination against Theiler's murine encephalomyelitis virus leads to alterations in demyelinating disease. J. Virol. 1999;73:993–1000. doi: 10.1128/jvi.73.2.993-1000.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  112. Tsiang H. Evidence for an intraaxonal transport of fixed and street rabies virus. J. Neuropathol. Exp. Neurol. 1979;38:286–299. doi: 10.1097/00005072-197905000-00008. [DOI] [PubMed] [Google Scholar]
  113. Tsunoda I, Kuang L.Q, Tolley N.D, Whitton J.L, Fujinami R.S. Enhancement of experimental allergic encephalomyelitis (EAE) by DNA immunization with myelin proteolipid protein (PLP) plasmid DNA. J. Neuropathol. Exp. Neurol. 1998;57:758–767. doi: 10.1097/00005072-199808000-00005. [DOI] [PubMed] [Google Scholar]
  114. Tsunoda I, Kurtz C.I, Fujinami R.S. Apoptosis in acute and chronic central nervous system disease induced by Theiler's murine encephalomyelitis virus. Virol. 1997;228:388–393. doi: 10.1006/viro.1996.8382. [DOI] [PubMed] [Google Scholar]
  115. Tsunoda L, Tolley N.D, Theil D.J, Whitton J.L, Kobayashi H, Fujinami R.S. Exacerbation of viral and autoimmune animal models for multiple sclerosis by bacterial DNA. Brain Pathol. 1999;9:481–493. doi: 10.1111/j.1750-3639.1999.tb00537.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  116. Walsh C.M, Matloubian M, Liu C.C, Ueda R, Kurahara C.G, Christensen J.L, Huang M.T, Young J.D, Ahmed R, Clark W.R. Vol. 91. 1994. Immune function in mice lacking the perforin gene; pp. 10854–10858. (Proc. Natl. Acad. Sci. U.S.A.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  117. Wang L.Y, Theil D.J, Whitton J.L, Fujinami R.S. Infection with a recombinant vaccinia virus encoding myelin proteolipid protein causes suppression of chronic relapsing-remitting experimental allergic encephalomyelitis. J. Neuroimmunol. 1999;96:148–157. doi: 10.1016/s0165-5728(99)00020-x. [DOI] [PubMed] [Google Scholar]
  118. Wang Y, Xiang Z, Pasquini S, Ertl H.C. Immune response to neonatal genetic immunization. Virol. 1997;228:278–284. doi: 10.1006/viro.1996.8384. [DOI] [PubMed] [Google Scholar]
  119. Weber T, Major E.O. Progressive multifocal leukoencephalopathy: molecular biology, pathogenesis and clinical impact. Intervirology. 1997;40:98–111. doi: 10.1159/000150537. [DOI] [PubMed] [Google Scholar]
  120. Welsh R.M, Nishioka W.K, Antia R, Dundon P.L. Mechanism of killing by virus-induced cytotoxic T lymphocytes elicited in vivo. J. Virol. 1990;64:3726–3733. doi: 10.1128/jvi.64.8.3726-3733.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  121. Whelan J.P, Wysocki C.J, Lampson L.A. Distribution of beta 2-microglobulin in olfactory epithelium: a proliferating neuropithelium not protected by a blood-tissue harrier. J. Immunol. 1986;137:2567–2571. [PubMed] [Google Scholar]
  122. Whitton J.L, Fujinami R.S. Viruses as triggers of autoimmunity: facts and fantasies. Curr. Opin. Microbiol. 1999;2:392–397. doi: 10.1016/s1369-5274(99)80069-1. [DOI] [PubMed] [Google Scholar]
  123. Whitton J.L, Oldstone M.B.A. The Immune Response to Viruses. In: Fields B.N, Knipe D.M, Howley P.M, editors. Fields' Virology. 4th ed. Lippincott Williams & Wilkins; Philadelphia: 2000. [Google Scholar]
  124. Whitton J.L, Sheng N, Oldstone M.B.A, McKee T.A. A “string-ofbeads” vaccine, comprising linked minigenes, confers protection from lethal-dose virus challenge. J. Virol. 1993;67:348–352. doi: 10.1128/jvi.67.1.348-352.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  125. Wiley C.A, Schrier R.D, Morey M, Achim C, Venable J.C, Nelson J.A. Pathogenesis of HIV encephalitis. Acta Pathol. Jpn. 1991;41:192–196. doi: 10.1111/j.1440-1827.1991.tb01646.x. [DOI] [PubMed] [Google Scholar]
  126. Will R.G, Ironside J.W, Zeidler M, Cousens S.N, Estibeiro K, Alperovitch A, Poser S, Pocchiari M, Hofman A, Smith PG. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet. 1996;347:921–925. doi: 10.1016/s0140-6736(96)91412-9. [DOI] [PubMed] [Google Scholar]
  127. Xiang Z.Q, Spitalnik S, Tran M, Wunner W.H, Cheng J, Ertl H.C. Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Virol. 1994;199:132–140. doi: 10.1006/viro.1994.1105. [DOI] [PubMed] [Google Scholar]
  128. Xiang Z.Q, Spitalnik S.L, Cheng J, Erikson J, Wojczyk B, Ertl H.C. Immune responses to nucleic acid vaccines to rabies virus. Virol. 1995;209:569–579. doi: 10.1006/viro.1995.1289. [DOI] [PubMed] [Google Scholar]
  129. Yamada M, Zurbriggen A, Fujinami R.S. Pathogenesis of Theiler's murine encephalomyelitis virus. Adv. Virus Res. 1991;39:291–320. doi: 10.1016/S0065-3527(08)60798-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  130. Yokoyama M, Hassett D.E, Zhang J, Whitton J.L. DNA immunization can stimulate florid local inflammation, and the antiviral immunity induced varies depending on injection site. Vaccine. 1997;15:553–560. doi: 10.1016/s0264-410x(97)00213-2. [DOI] [PubMed] [Google Scholar]
  131. Yokoyama M, Zhang J, Whitton J.L. DNA immunization confers protection against lethal hocytic choriomeningitis virus infection. J. Virol. 1995;69:2684–2688. doi: 10.1128/jvi.69.4.2684-2688.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  132. Yokoyama M, Zhang J, Whitton J.L. DNA immunization: effects of vehicle and route of administration on the induction of protective antiviral immunity. FEMS Immunol. Med. Microbiol. 1996;14:221–230. doi: 10.1111/j.1574-695X.1996.tb00290.x. [DOI] [PubMed] [Google Scholar]
  133. Zarozinski C.C, Fynan E.F, Selin L.K, Robinson H.L, Welsh R.M. Protective CTL-dependent immunity and enhanced immunopathology in mice immunized by particle bombardment with DNA encoding an internal virion protein. J. Immunol. 1995;154:4010–4017. [PubMed] [Google Scholar]
  134. Zychlinsky A, Zheng L.M, Liu C.C, Young J.D. Cytolytic lymphocytes induce both apoptosis and necrosis in target cells. J. Immunol. 1991;146:393–400. [PubMed] [Google Scholar]

Articles from Advances in Virus Research are provided here courtesy of Elsevier

RESOURCES